Navigation Links
Bionovo Announces Third Quarter 2011 Highlights and Financial Results
Date:11/10/2011

s February 2011 public offering offset by clinical trial costs and operating expenses and capital expenditures to support the Menerba manufacturing facility in Hayward, California.

Conference CallBionovo will conduct a conference call and webcast to review the Company's financial results on Monday, November 14, 2011, at 1:30 PM PST, when further information on the non-clinical and clinical progress of Menerba will also be provided.

Interested parties can access the call by dialing 800-705-7067 or can listen via a live audio only webcast, which can be found at http://bionovo.com/investors/events. A replay of the call will be available by dialing 800-633-8284 (replay code 21544924) through November 18, 2011, and archived via audio webcast at http://bionovo.com/investors/events.

About Bionovo, Inc.Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California, and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

Forward Looking StatementsThis release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
2. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
3. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
4. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
6. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
7. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
8. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
9. Bionovo Announces 2010 Highlights and Year-End Financial Results
10. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
11. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014 CorMedix Inc. ("CorMedix") ... developing and commercializing therapeutic products for the prevention ... announces the amendment and restatement of its outstanding ... and related warrants, as well as the warrants ... warrant financing, to remove anti-dilution, price reset and ...
(Date:9/16/2014)... , Sept. 16, 2014 Imprimis Pharmaceuticals, ... company dedicated to delivering high quality and novel medicines ... that Chief Executive Officer Mark Baum will ... Craig-Hallum Alpha Select Conference in New York City.  Mr. ... Go Dropless™ campaign in ophthalmology. The presentation is ...
(Date:9/16/2014)... Sept. 16, 2014  Wearable sports and activity ... less than two years, producing a massive amount ... huge opportunity exists for leveraging this data to ... ) introduced a first-of-its-kind wearable analytics platform for ... of clinical research linking activity and health risks, ...
Breaking Medicine Technology:CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3
... Qualcomm Incorporated (NASDAQ: QCOM ), as ... Centers for Disease Control and Prevention (KCDC), and Korea ... of Understanding for a project that will benefit patients ... Quality Care , which will utilize 3G-enabled applications and ...
... Experts in Telehealth(SM), received one of six national ... Affairs for Home Telehealth Devices and Services.  Cardiocom ... services portfolio which includes its Commander Home Telehealth ... Patient Management Software.   "We are ...
Cached Medicine Technology:Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea 2Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea 3Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea 4Cardiocom Receives U.S. Department of Veteran Affairs National Contract for Home Telehealth Devices 2
(Date:9/16/2014)... make discoveries everyday, but that doesn,t mean the findings ... for example, the neonatal mortality rate is 10 times ... found that applying an inexpensive topical solution of chlorhexidine ... mortality rate by 24 percent, many Indian parents did ... is not that we don,t have solutions to solve ...
(Date:9/16/2014)... WASHINGTON D.C., September 16, 2014 A team of ... Medicine has developed a new model to study the ... determine how these motions relate to communication within a ... Escherichia coli bacteria to a microcantilever ... a diving board thus coupling its motion to ...
(Date:9/16/2014)... prospective study that compared patient-reported outcomes of a ... demonstrates that single fraction radiation therapy (SFRT) is ... (MFRT) when pain, function and quality of life ... the American Society for Radiation Oncology,s (ASTRO,s) 56th ... in patients, pain, function and degree of distress ...
(Date:9/16/2014)... Beginning October 1st 2014, Dallas’ Park ... for its clients who book a recurring visit schedule, and ... they buy. Most recurring visit clients are ones that ... but others include clients whose unique work schedules or lifestyles ... a daily basis. The newly introduced 15-minute visit length ...
(Date:9/16/2014)... Founded by former Miami Beach mayoral ... political organization fighting to legalize medical marijuana in Florida. ... After Party recently commissioned a shot-for-shot parody video of ... the movie “Grease.” ( http://youtu.be/zdcvhUgeDRg ) , Called “You’re ... musical parody faithfully recreates the carnival scene made famous ...
Breaking Medicine News(10 mins):Health News:Pairing social networks with social motives to close the science gap 2Health News:Pairing social networks with social motives to close the science gap 3Health News:And so they beat on, flagella against the cantilever 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 2Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 3Health News:Miami Beach Politician Drives 1,400 Miles to Texas to Shoot “Grease” Parody Video Supporting the Legalization of Medical Marijuana in Florida 2
... Technology Integrated with the Award Winning ... CytoViva ... Inc., a leading provider,of optical imaging solutions to the ... with its advanced,nano- scale microscope system. This combination of ...
... Aug. 21 Hospira, Inc.,(NYSE: HSP ... delivery,company, today announced new national agreements with ... Premier,s 2,000 member,hospitals with access to special ... general-purpose medication infusion devices, related,sets and disposables, ...
... Democratic National,Convention, WASHINGTON, Aug. 21 RCRC ... hold two events at the Democratic,National Convention to ... campaign. RCRC,s president, The Reverend Dr. Carlton W.,Veazey, ... available for media,interviews. RCRC is the national coalition ...
... Press Club (Zenger room), WASHINGTON, Aug. 21 ... Club:, Grace-Marie Turner, CEO Galen Institute - ... debate over free-market ideas of,health reform, Melinna ... founder of a,coding system and billing platform that ...
... commitment to industry best practices, meets new ... ... health care consulting,practice Halleland Health Consulting announces the development ... benefit managers (PBMs) seeking the level of excellence required,by ...
... FRANCISCO, Aug. 21 Bruce Bodaken,Chairman, President & CEO ... on the 2008 Rocky Mountain Roundtable on Health, Wellness ... on Monday,August 25, 2008, 9:30 a.m. MDT at Boettcher ... discuss the importance of wellness programs,in health reform, and ...
Cached Medicine News:Health News:CytoViva(R) Introduces Breakthrough Nano-Technology Research Tool 2Health News:Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment 2Health News:Halleland Health Consulting Establishes URAC Accreditation Program 2Health News:Blue Shield of California CEO to Speak at Democratic Convention Host Committee's Health Roundtable in Denver 2
... ability to fuse multiple image sets in ... for treatment planning and follow-up. ImageFusion aligns ... complementary features of different scan types. Radionics ... so clinicians can capitalize on the unique ...
... Framelink Stereotactic Linking System simplifies planning for ... (DBS). This software integrates multiple patient ... recording data, to assist in charting the ... target location. Framelink interfaces seamlessly with ...
It provides cranial support in either supine or semi-sitting procedures....
Mathews hand drill, with knurled shank and rotating head....
Medicine Products: